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BMI = body mass index; ICU = intensive care unit; MRSA = methicillin-resistant Staphylococcus aureus; TBI = traumatic brain injury; VAP = ventilator-
associated pneumonia.
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Infection and sepsis continue to dominate the critical care
literature, and in particular a condensation of evidence-based
practice in this area, from the Surviving Sepsis Campaign,
was published in March. Choosing the right resuscitation
fluid in the right clinical setting remains contentious, and why
don’t we include body mass index in severity of illness
scoring?
Nosocomial infection
In a report [1] and accompanying editorial [2], the March
issue of Intensive Care Medicine examined therapy for
ventilator-associated pneumonia (VAP) caused by Gram-
positive organisms. Methicillin-resistant Staphylococcus
aureus (MRSA) in VAP accounts for 50% of all cases due to
S. aureus, which is the micro-organism most commonly
responsible for nosocomial pneumonia, with mortality ranging
from 14% to 47% [3].
Kollef and coworkers [1] compared linezolid with vancomycin
therapy for MRSA VAP. In their retrospective analysis of two
randomized, double-blind studies, 544 patients with
suspected Gram-positive VAP (including 264 with proven
Gram-positive VAP and 91 with MRSA) were treated with
linezolid 600 mg or vancomycin 1 g every 12 hours for
7–21 days, both combined with aztreonam (a monobactam
specific to Gram-negative organisms). Clinical cure rates
assessed 12–28 days after therapy significantly favoured the
linezolid group among Gram-positive and MRSA patients,
with clinical cure odds ratios of 2.4 for Gram-positive VAP
and 20.0 for MRSA VAP. Linezolid was an independent
predictor for survival, with odds ratios of 2.6 for
Gram-positive VAP and 4.6 for MRSA VAP. This difference is
probably due to linezolid achieving much higher levels in lung
tissue than vancomycin, which has relatively poor pulmonary
penetration.
A further study relating to nosocomial infection reiterated the
importance of early and effective nutrition [4]. Nosocomial
infections acquired by intensive care unit (ICU) patients
account for nearly 50% of all infections in hospitals and may
directly cause or contribute to death in up to 10% of cases [5].
The study investigated whether caloric intake is associated
with risk for nosocomial bloodstream infection in critically ill
medical patients. In this prospective cohort study the caloric
intake of 138 adult patients on the medical ICU was recorded
and grouped into <25%, 25–49%, 50–74% and ≥75% of
their recommended daily calorie intake. Nosocomial
bloodstream infection was detected by routine infection control
surveillance methods. Bloodstream infection occurred in
22.4% of patients with a significantly lower risk for infection in
those groups receiving >25% of their recommended daily
caloric intake. Given the potential morbidity and mortality
associated with nosocomial infection and the effects of low
caloric intake on other ICU outcomes such as weaning,
aggressive nutritional care is worthy of repeated emphasis.
Staying with management of sepsis, March witnessed a
seminal publication, which is a ‘must read’ [6]. The
multinational Surviving Sepsis Campaign has produced a
document laying out evidence-based guidelines for the
management of severe sepsis and septic shock following
expert systematic review of the literature, a consensus
conference and numerous roundtable debates. Key areas
covered in this landmark review include initial resuscitation,
early identification of sepsis source and causative organism,
empirical and definitive antimicrobial therapy, fluid therapy,
vasopressor/inotropic therapy, steroid therapy, recombinant
activated protein C therapy, blood product administration,
mechanical ventilation, sedation, glycaemic control, renal
replacement therapy, and deep venous thrombosis and
stress ulcer prophylaxis.
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This report provides a foundation on which the bedside
clinician can build a sepsis care bundle. The authors are keen
to stress that this is a dynamic process, and we must now
endeavour to document the impact of our management
strategies on patient outcome, and thereby carry the
evidence-based process forward.
Fluids for brains
Comparison studies in heterogeneous groups between
crystalloids and colloids commonly yield conflicting results,
but certain subgroups of patients may benefit from one type
of fluid over another. For example, many researchers have felt
that hypertonic saline holds advantages over other
resuscitation fluids in the management of trauma, especially
when associated with traumatic brain injury (TBI). In
unselected trauma patients treatment with hypertonic saline
increases blood pressure and reduces intracranial pressure,
in addition to having other theoretical advantages such as
improved microcirculatory flow. However, clinical outcome
studies, most of which have been small, have failed to
produce consistent results. Cooper and coworkers [7]
investigated whether prehospital resuscitation with
intravenous hypertonic saline improves long-term outcome in
patients with severe TBI as compared with conventional
fluids. In this double-blind, prospective, randomized
controlled trial, 229 patients with TBI (Glascow Coma Scale
score <9) and hypotension (systolic blood pressure
<100 mmHg) received either 250 ml 7.5% saline or 250 ml
Ringer’s lactate, in addition to protocol driven conventional
fluid resuscitation. Unfortunately, once again there was no
difference between the two groups in terms of either survival
or neurological outcome. The difficulty of studying a single
intervention in such a clinically complex situation such as
trauma, which demands many interventions, goes some way
to explaining the contradictory results in this field. However,
survival in both groups was high, which may reflect the
benefit of aggressive fluid and haemodynamic management.
Obesity in the intensive care unit
It should come as no surprise to intensivists that obesity
increases morbidity and mortality in ICUs; however, body
mass index (BMI) is rarely used in scoring systems. Three
prospective studies recently investigated the relationship
between BMI and mortality, yielding conflicting results.
Bercault and coworkers [8] matched 170 ventilated obese
patients (BMI >30 kg/m2) with 170 ventilated patients with
BMI within the ideal range. Matching was based on a number
of patient and clinical factors, including the Simplified Acute
Physiology Score II. Obesity was found to be an independent
risk factor for ICU death. This was especially true for the
younger and ‘sicker’ patients, and was explained by a higher
number of complications among the obese patients.
In the second study [9], 1698 patients were divided into four
groups based on BMI. Only those with the lowest BMI
(<18.5 kg/m2) exhibited a higher independent mortality.
There was no increase in mortality in the obese group.
Finally, a study was published in Chest [10] that was based
on all admissions to a medical ICU over a period of 1 year
(n = 813). The obese (BMI >75th centile for the study
population) and nonobese (BMI <75th centile) were
compared with respect to independent predictors of
mortality. The observed mortality in obese patients was
greater than that predicted by their Simplified Acute
Physiology Score II, and the authors went on to conclude
that a BMI greater than 27 kg/m2 was an independent
predictor of mortality.
What can we conclude from these studies? The findings are
generally tricky to interpret as a result of heterogeneous case
mix. The first study went to great effort to match patients [8],
whereas in the second report there were significant clinical
and demographical differences between groups [9]. In the
latter of those two studies a low BMI was found to be a
significant risk factor, presumably representing a lack of
metabolic substrate reserve in these patients, whereas a high
BMI was not. The editorial in Critical Care Medicine that
accompanies the first report [11] gives sensible advice;
observational studies and clinical experience show us that
the obese are vulnerable to complications, and therefore we
should redouble our efforts in prevention, diagnosis and early
treatment of complications in this group.
Postpyloric feeding
Intensive Care Monitor recently published an interesting
review of a paper comparing clinical outcomes, pulmonary
complications and success of caloric goals with gastric
versus postpyloric feeding [12]. The results did not support
postpyloric feeding in preference to conventional gastric
feeding because there were no differences between the two
groups in terms of incidence of pneumonia, percentage of
caloric goal achieved, total caloric intake, length of stay, or
mortality. However, the analysis still recommended the
postpyloric route for those at high risk for aspiration or when
gastric feeding fails – just don’t feed them to a patient with a
BMI in excess of 30 kg/m2.
Other recommended papers
The March/April edition of Intensive Care Monitor reports on
the apparently highly successful implementation of Medical
Emergency Teams in Australia [13], although the editorial
comment suggests a degree of scepticism. A protocol based
strategy for weaning from mechanical ventilation, given
credence in the Surviving Sepsis Campaign guidelines, was
found to be of no benefit in a prospective study published in
the American Journal of Respiratory and Critical Care [14];
the conclusions suggested that a structured ICU ward round
is all that is required. Finally, a helpful review of the
management of acute asthma in adults was published in
Chest [15].150
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